272 related articles for article (PubMed ID: 32796711)
21. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
[TBL] [Abstract][Full Text] [Related]
22. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
[TBL] [Abstract][Full Text] [Related]
23. Aconitase 2 sensitizes MCF-7 cells to cisplatin eliciting p53-mediated apoptosis in a ROS-dependent manner.
Ciccarone F; De Falco P; Ciriolo MR
Biochem Pharmacol; 2020 Oct; 180():114202. PubMed ID: 32818504
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
25. Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis.
Mailloux A; Grenet K; Bruneel A; Bénéteau-Burnat B; Vaubourdolle M; Baudin B
Eur J Cell Biol; 2001 Jun; 80(6):442-9. PubMed ID: 11484935
[TBL] [Abstract][Full Text] [Related]
26. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
27. Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells.
Wesierska-Gadek J; Wandl S; Kramer MP; Pickem C; Krystof V; Hajek SB
J Cell Biochem; 2008 Dec; 105(5):1161-71. PubMed ID: 18846503
[TBL] [Abstract][Full Text] [Related]
28. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
Lindemann A; Patel AA; Silver NL; Tang L; Liu Z; Wang L; Tanaka N; Rao X; Takahashi H; Maduka NK; Zhao M; Chen TC; Liu W; Gao M; Wang J; Frank SJ; Hittelman WN; Mills GB; Myers JN; Osman AA
Clin Cancer Res; 2019 Sep; 25(18):5650-5662. PubMed ID: 31308060
[TBL] [Abstract][Full Text] [Related]
29. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
31. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway.
Huang H; Chen AY; Ye X; Li B; Rojanasakul Y; Rankin GO; Chen YC
Int J Oncol; 2015 Oct; 47(4):1494-502. PubMed ID: 26315556
[TBL] [Abstract][Full Text] [Related]
32. Synergistic anti-oral cancer effects of UVC and methanolic extracts of Cryptocarya concinna roots via apoptosis, oxidative stress and DNA damage.
Chang HW; Tang JY; Yen CY; Chang HS; Huang HW; Chung YA; Chen IS; Huang MY
Int J Radiat Biol; 2016 May; 92(5):263-72. PubMed ID: 26887975
[TBL] [Abstract][Full Text] [Related]
33. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
Wang Z; Xu Z; Zhu G
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
[TBL] [Abstract][Full Text] [Related]
34. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents.
Sanchez-Prieto R; Rojas JM; Taya Y; Gutkind JS
Cancer Res; 2000 May; 60(9):2464-72. PubMed ID: 10811125
[TBL] [Abstract][Full Text] [Related]
35. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
36. Nuclear accumulation of p53 protein and apoptosis induced by various anticancer agents, u.v.-irradiation and heat shock in primary normal human skin fibroblasts.
Chikayama S; Sugano T; Takahashi Y; Ikeda M; Kimura S; Kobayashi Y; Kondo M
Int J Oncol; 2000 Jun; 16(6):1117-24. PubMed ID: 10811983
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.
Mariggiò MA; Cafaggi S; Ottone M; Parodi B; Vannozzi MO; Mandys V; Viale M
Invest New Drugs; 2004 Jan; 22(1):3-16. PubMed ID: 14707490
[TBL] [Abstract][Full Text] [Related]
38. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.
Colin DJ; Limagne E; Ragot K; Lizard G; Ghiringhelli F; Solary É; Chauffert B; Latruffe N; Delmas D
Cell Death Dis; 2014 Nov; 5(11):e1533. PubMed ID: 25412311
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy combined to cisplatin potentiates cell death responses of cervical cancer cells.
de Freitas LM; Serafim RB; de Sousa JF; Moreira TF; Dos Santos CT; Baviera AM; Valente V; Soares CP; Fontana CR
BMC Cancer; 2017 Feb; 17(1):123. PubMed ID: 28187758
[TBL] [Abstract][Full Text] [Related]
40. Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing.
Paek AL; Liu JC; Loewer A; Forrester WC; Lahav G
Cell; 2016 Apr; 165(3):631-42. PubMed ID: 27062928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
